Home

Download

Statistics

Examples

Help

Contact

Editing gene: GABRP (CAeditome ID:2568)

Gene summary for GABRP

Gene summary

Gene information	Gene symbol	GABRP
	Gene ID	2568
	Gene name	gamma-aminobutyric acid type A receptor subunit pi
	Synonyms	-
	Cytomap	5q35.1
	Type of gene	protein-coding
	Description	gamma-aminobutyric acid receptor subunit piGABA(A) receptor subunit piGABA(A) receptor, pigamma-aminobutyric acid (GABA) A receptor, pigamma-aminobutyric acid type A receptor pi subunit
	Modification date	20210518
	UniProtAcc	O00591
	Context

Gene ontology of each this gene with evidence of Inferred from Direct Assay (IDA) from Entrez

Gene

GO ID

GO term

PubMed ID

Top

RNA A-to-I events for GABRP

RNA A-to-I editing events across TCGA 33 cancers data sets based on Ensembl gene isoform structure.

RNA editing frequencies across 33 cancers of gene: ENSG00000094755.15

RNA A-to-I editing events in Cancer.

CAediting_446347(170798121, +), CAediting_446348(170798122, +), CAediting_446349(170798167, +), CAediting_446350(170798171, +), CAediting_446351(170798181, +), CAediting_446352(170798183, +), CAediting_446353(170798197, +), CAediting_446354(170798226, +), CAediting_446355(170798240, +), CAediting_446356(170798248, +), CAediting_446357(170798293, +), CAediting_446358(170798302, +), CAediting_446359(170798303, +), CAediting_446360(170798315, +), CAediting_446361(170798317, +), CAediting_446362(170800674, +), CAediting_446363(170800688, +), CAediting_446364(170800690, +), CAediting_446365(170800691, +), CAediting_446366(170800696, +), CAediting_446367(170800712, +), CAediting_446368(170800744, +), CAediting_446369(170800745, +), CAediting_446370(170800759, +), CAediting_446371(170800760, +), CAediting_446372(170800770, +), CAediting_446373(170800781, +), CAediting_446374(170800784, +), CAediting_446375(170800785, +), CAediting_446376(170800786, +), CAediting_446377(170800787, +), CAediting_446378(170800788, +), CAediting_446379(170800790, +), CAediting_446380(170800793, +), CAediting_446381(170800799, +), CAediting_446382(170800803, +), CAediting_446383(170800825, +), CAediting_446384(170800826, +), CAediting_446385(170800831, +), CAediting_446386(170800871, +), CAediting_446387(170800887, +), CAediting_446388(170800925, +), CAediting_446389(170803870, +), CAediting_446390(170803877, +), CAediting_446391(170803881, +), CAediting_446392(170803951, +), CAediting_446393(170803957, +), CAediting_446394(170806598, +), CAediting_446395(170811121, +), CAediting_446396(170811122, +), CAediting_446397(170811123, +), CAediting_446398(170811126, +), CAediting_446399(170811129, +), CAediting_446400(170811135, +), CAediting_446401(170811138, +), CAediting_446402(170811143, +), CAediting_446403(170811144, +), CAediting_446404(170811149, +), CAediting_446405(170811182, +), CAediting_446406(170811184, +), CAediting_446407(170811192, +), CAediting_446408(170811198, +), CAediting_446409(170811200, +), CAediting_446410(170811208, +), CAediting_446411(170811209, +), CAediting_446412(170811211, +),

Top

RNA editing positional annotations for GABRP using Annovar

Protein coding RNA editing(s).

CAeditome ID

Position

Variant type

ENST

NTchange

AAchange

SIFT_score

Polyphen2_HVAR_score

PROVEAN_pred

Gene structure information of RNA editing(s).

CAeditome ID	Position	Variant type
CAediting_446347	chr5_170798121_+	intronic
CAediting_446348	chr5_170798122_+	intronic
CAediting_446349	chr5_170798167_+	intronic
CAediting_446350	chr5_170798171_+	intronic
CAediting_446351	chr5_170798181_+	intronic
CAediting_446352	chr5_170798183_+	intronic
CAediting_446353	chr5_170798197_+	intronic
CAediting_446354	chr5_170798226_+	intronic
CAediting_446355	chr5_170798240_+	intronic
CAediting_446356	chr5_170798248_+	intronic
CAediting_446357	chr5_170798293_+	intronic
CAediting_446358	chr5_170798302_+	intronic
CAediting_446359	chr5_170798303_+	intronic
CAediting_446360	chr5_170798315_+	intronic
CAediting_446361	chr5_170798317_+	intronic
CAediting_446362	chr5_170800674_+	intronic
CAediting_446363	chr5_170800688_+	intronic
CAediting_446364	chr5_170800690_+	intronic
CAediting_446365	chr5_170800691_+	intronic
CAediting_446366	chr5_170800696_+	intronic
CAediting_446367	chr5_170800712_+	intronic
CAediting_446368	chr5_170800744_+	intronic
CAediting_446369	chr5_170800745_+	intronic
CAediting_446370	chr5_170800759_+	intronic
CAediting_446371	chr5_170800760_+	intronic
CAediting_446372	chr5_170800770_+	intronic
CAediting_446373	chr5_170800781_+	intronic
CAediting_446374	chr5_170800784_+	intronic
CAediting_446375	chr5_170800785_+	intronic
CAediting_446376	chr5_170800786_+	intronic
CAediting_446377	chr5_170800787_+	intronic
CAediting_446378	chr5_170800788_+	intronic
CAediting_446379	chr5_170800790_+	intronic
CAediting_446380	chr5_170800793_+	intronic
CAediting_446381	chr5_170800799_+	intronic
CAediting_446382	chr5_170800803_+	intronic
CAediting_446383	chr5_170800825_+	intronic
CAediting_446384	chr5_170800826_+	intronic
CAediting_446385	chr5_170800831_+	intronic
CAediting_446386	chr5_170800871_+	intronic
CAediting_446387	chr5_170800887_+	intronic
CAediting_446388	chr5_170800925_+	intronic
CAediting_446389	chr5_170803870_+	intronic
CAediting_446390	chr5_170803877_+	intronic
CAediting_446391	chr5_170803881_+	intronic
CAediting_446392	chr5_170803951_+	intronic
CAediting_446393	chr5_170803957_+	intronic
CAediting_446394	chr5_170806598_+	intronic
CAediting_446395	chr5_170811121_+	intronic
CAediting_446396	chr5_170811122_+	intronic
CAediting_446397	chr5_170811123_+	intronic
CAediting_446398	chr5_170811126_+	intronic
CAediting_446399	chr5_170811129_+	intronic
CAediting_446400	chr5_170811135_+	intronic
CAediting_446401	chr5_170811138_+	intronic
CAediting_446402	chr5_170811143_+	intronic
CAediting_446403	chr5_170811144_+	intronic
CAediting_446404	chr5_170811149_+	intronic
CAediting_446405	chr5_170811182_+	intronic
CAediting_446406	chr5_170811184_+	intronic
CAediting_446407	chr5_170811192_+	intronic
CAediting_446408	chr5_170811198_+	intronic
CAediting_446409	chr5_170811200_+	intronic
CAediting_446410	chr5_170811208_+	intronic
CAediting_446411	chr5_170811209_+	intronic
CAediting_446412	chr5_170811211_+	intronic

Repat-regional RNA editing(s).

CAeditome ID	Position	Repeat family	Repeat sub family	Repeat name
CAediting_446347	chr5_170798121_+	SINE	Alu	AluY
CAediting_446348	chr5_170798122_+	SINE	Alu	AluY
CAediting_446349	chr5_170798167_+	SINE	Alu	AluY
CAediting_446350	chr5_170798171_+	SINE	Alu	AluY
CAediting_446351	chr5_170798181_+	SINE	Alu	AluY
CAediting_446352	chr5_170798183_+	SINE	Alu	AluY
CAediting_446353	chr5_170798197_+	SINE	Alu	AluY
CAediting_446354	chr5_170798226_+	SINE	Alu	AluY
CAediting_446355	chr5_170798240_+	SINE	Alu	AluY
CAediting_446356	chr5_170798248_+	SINE	Alu	AluY
CAediting_446357	chr5_170798293_+	SINE	Alu	AluY
CAediting_446358	chr5_170798302_+	SINE	Alu	AluY
CAediting_446359	chr5_170798303_+	SINE	Alu	AluY
CAediting_446360	chr5_170798315_+	SINE	Alu	AluY
CAediting_446361	chr5_170798317_+	SINE	Alu	AluY
CAediting_446362	chr5_170800674_+	SINE	Alu	AluSq2
CAediting_446363	chr5_170800688_+	SINE	Alu	AluSq2
CAediting_446364	chr5_170800690_+	SINE	Alu	AluSq2
CAediting_446365	chr5_170800691_+	SINE	Alu	AluSq2
CAediting_446366	chr5_170800696_+	SINE	Alu	AluSq2
CAediting_446367	chr5_170800712_+	SINE	Alu	AluSq2
CAediting_446368	chr5_170800744_+	SINE	Alu	AluSq2
CAediting_446369	chr5_170800745_+	SINE	Alu	AluSq2
CAediting_446370	chr5_170800759_+	SINE	Alu	AluSq2
CAediting_446371	chr5_170800760_+	SINE	Alu	AluSq2
CAediting_446372	chr5_170800770_+	SINE	Alu	AluSq2
CAediting_446373	chr5_170800781_+	SINE	Alu	AluSq2
CAediting_446374	chr5_170800784_+	SINE	Alu	AluSq2
CAediting_446375	chr5_170800785_+	SINE	Alu	AluSq2
CAediting_446376	chr5_170800786_+	SINE	Alu	AluSq2
CAediting_446377	chr5_170800787_+	SINE	Alu	AluSq2
CAediting_446378	chr5_170800788_+	SINE	Alu	AluSq2
CAediting_446379	chr5_170800790_+	SINE	Alu	AluSq2
CAediting_446380	chr5_170800793_+	SINE	Alu	AluSq2
CAediting_446381	chr5_170800799_+	SINE	Alu	AluSq2
CAediting_446382	chr5_170800803_+	SINE	Alu	AluSq2
CAediting_446383	chr5_170800825_+	SINE	Alu	AluSq2
CAediting_446384	chr5_170800826_+	SINE	Alu	AluSq2
CAediting_446385	chr5_170800831_+	SINE	Alu	AluSq2
CAediting_446386	chr5_170800871_+	SINE	Alu	AluSq2
CAediting_446387	chr5_170800887_+	SINE	Alu	AluSq2
CAediting_446388	chr5_170800925_+	SINE	Alu	AluSq2
CAediting_446389	chr5_170803870_+	SINE	Alu	AluSq2
CAediting_446390	chr5_170803877_+	SINE	Alu	AluSq2
CAediting_446391	chr5_170803881_+	SINE	Alu	AluSq2
CAediting_446392	chr5_170803951_+	SINE	Alu	AluSq2
CAediting_446393	chr5_170803957_+	SINE	Alu	AluSq2
CAediting_446394	chr5_170806598_+	SINE	Alu	AluSz6
CAediting_446395	chr5_170811121_+	SINE	MIR	MIR
CAediting_446396	chr5_170811122_+	SINE	MIR	MIR
CAediting_446397	chr5_170811123_+	SINE	MIR	MIR
CAediting_446398	chr5_170811126_+	SINE	MIR	MIR
CAediting_446399	chr5_170811129_+	SINE	MIR	MIR
CAediting_446400	chr5_170811135_+	SINE	MIR	MIR
CAediting_446401	chr5_170811138_+	SINE	MIR	MIR
CAediting_446402	chr5_170811143_+	SINE	MIR	MIR
CAediting_446403	chr5_170811144_+	SINE	MIR	MIR
CAediting_446404	chr5_170811149_+	SINE	MIR	MIR
CAediting_446407	chr5_170811192_+	SINE	MIR	MIR
CAediting_446408	chr5_170811198_+	SINE	MIR	MIR
CAediting_446409	chr5_170811200_+	SINE	MIR	MIR
CAediting_446410	chr5_170811208_+	SINE	MIR	MIR
CAediting_446411	chr5_170811209_+	SINE	MIR	MIR
CAediting_446412	chr5_170811211_+	SINE	MIR	MIR

Top

RNA A-to-I editing events in the alternative splicing sites for GABRP

RNA A-to-I editing(s) in the alternative splicing sites.

AStype

CAeditomID

Editing position

AS position

AS direction

Exonic location

Wildtype sequence

Wildtype splicing strength

RNA edited sequence

RNA edited splicing strength

Differential percent of spliced in (PSI) between RNA A-to-I edited and non-edited samples for ENSG00000094755.15.GABRP.

Correlation between RNA A-to-I editing and PSI for ENSG00000094755.15.GABRP.

Top

Differntial gene expression between RNA A-to-I edited versus non-edited samples for GABRP

Differential gene expressions between RNA A-to-I edited and non-edited tumor samples.
* The grey color means N/A.

Correlation between RNA A-to-I editing and gene expression.

- Differentially expressed gene between RNA A-to-I edited samples versus non-edited samples.
* Click on the image to enlarge it in a new window.

BRCA.CAediting_446401.ENSG00000094755.GABRP.png
Soverview

Top

Protein coding region RNA A-to-I editings for GABRP

- Lollipop plot for RNA A-to-I editings across protein structure.
* Click on the image to enlarge it in a new window.

Top

The effects of the RNA editing to the miRNA binding sites for GABRP

**If you are searching a miRNA gene with RNA editing events in its seed regions, please see the search pages of miRNA targets to discover the effects of this RNA editing event to miRNA regulations. For more information, please check the files in the Download page.

RNA A-to-I editing in the 3'-UTR regions of mRNA gained miRNA binding sites.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

RNA A-to-I editing in the 3'-UTR regions of mRNA lost miRNA binding sites.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

RNA A-to-I editing in lncRNA gained miRNA binding sites.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

RNA A-to-I editing in lncRNA lost miRNA binding sites.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

RNA A-to-I editing in miRNAs gained binding to lncRNA.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

RNA A-to-I editing in miRNAs lost binding to lncRNA.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

RNA A-to-I editing in miRNAs gained binding to the 3'-UTR region of mRNA.

CAeditom_ID	Position	ENSG	ENST	miRNA	Targetscan start	Targetscan end	Targetscan score	Miranda start	Miranda end	Miranda score	Miranda energy
CAediting_748296	chr10_51299626_+	ENSG00000094755.15	ENST00000518525	hsa-miR-605-3p	170813525	170813531	7mer-m8	170813510	170813532	141	-18.76
CAediting_393	chr1_1167164_+	ENSG00000094755.15	ENST00000518525	hsa-miR-200b-3p	170813285	170813290	6mer	170813269	170813291	143	-19.1
CAediting_393	chr1_1167164_+	ENSG00000094755.15	ENST00000519385	hsa-miR-200b-3p	170812041	170812047	7mer-m8	170812028	170812048	146	-14.57
CAediting_748296	chr10_51299626_+	ENSG00000094755.15	ENST00000265294	hsa-miR-605-3p	170813525	170813531	7mer-m8	170813510	170813532	141	-18.76
CAediting_393	chr1_1167164_+	ENSG00000094755.15	ENST00000265294	hsa-miR-200b-3p	170813285	170813290	6mer	170813269	170813291	143	-19.1
CAediting_1229415	chr17_67471547_+	ENSG00000094755.15	ENST00000518525	hsa-miR-548aa	170813378	170813384	7mer-m8	170813361	170813385	165	-16.96
CAediting_1399425	chr20_1392958_-	ENSG00000094755.15	ENST00000518525	hsa-miR-6869-5p	170814035	170814041	7mer-m8	170814021	170814042	141	-18.32
CAediting_396018	chr5_1062918_-	ENSG00000094755.15	ENST00000518525	hsa-miR-4635	170812607	170812613	7mer-m8	170812594	170812614	140	-18.71
CAediting_442554	chr5_154685830_+	ENSG00000094755.15	ENST00000518525	hsa-miR-1303	170813530	170813537	8mer-1a	170813516	170813537	160	-22.73
CAediting_1229415	chr17_67471547_+	ENSG00000094755.15	ENST00000265294	hsa-miR-548aa	170813378	170813384	7mer-m8	170813361	170813385	165	-16.96
CAediting_1399425	chr20_1392958_-	ENSG00000094755.15	ENST00000265294	hsa-miR-6869-5p	170814035	170814041	7mer-m8	170814021	170814042	141	-18.32
CAediting_396018	chr5_1062918_-	ENSG00000094755.15	ENST00000265294	hsa-miR-4635	170812607	170812613	7mer-m8	170812594	170812614	140	-18.71
CAediting_442554	chr5_154685830_+	ENSG00000094755.15	ENST00000265294	hsa-miR-1303	170813530	170813537	8mer-1a	170813516	170813537	160	-22.73

RNA A-to-I editing in miRNAs lost binding to the 3'-UTR mRNA.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

Differentially expressed gene-miRNA network

Top

The effects of the RNA editing to the stability of the RNA structures for GABRP

- RNA A-to-I editing in mRNA.
* Click on the image to enlarge it in a new window.

ENST

ENST type

RNA structure without RNA A-to-I editing.

RNA structure with RNA A-to-I editing.

RNA A-to-I editing in RNA structures for Minimum free energy (MFE).

CAeditom_ID

ENST

Editing_Position

MFE_withoneAI

MFE_withoutAI

MFE_withmultipleAI

Top

Relation with ADAR for GABRP

Correlation between ADAR gene expression and RNA editing frequency

Cancer	CAeditomID	position	ADAR1 (p-val)	ADAR1 (coeff.)	ADAR2 (p-val)	ADAR2 (coeff.)	ADAR3 (p-val)	ADAR3 (coeff.)
BRCA	CAediting_446399	chr5_170811129_+	3.82742809259334e-05	0.334922299882121	.	.	.	.
STAD	CAediting_446399	chr5_170811129_+	0.000561503166797982	0.425714791262393	.	.	.	.
BRCA	CAediting_446400	chr5_170811135_+	0.00927396356422114	0.211791177875355	.	.	.	.
STAD	CAediting_446400	chr5_170811135_+	0.0136884739675294	0.311601348480844	.	.	.	.
BRCA	CAediting_446401	chr5_170811138_+	0.027387276809256	0.151169279523469	.	.	.	.
CESC	CAediting_446401	chr5_170811138_+	0.0103000628331341	0.278539018095867	.	.	.	.
STAD	CAediting_446401	chr5_170811138_+	0.024458539795666	0.257965880981352	.	.	.	.
BRCA	CAediting_446410	chr5_170811208_+	0.000318076247484322	0.30860112596494	.	.	.	.
STAD	CAediting_446410	chr5_170811208_+	0.00226824091814134	0.377801377161269	.	.	.	.
BRCA	CAediting_446411	chr5_170811209_+	0.00173529923025344	0.280736390961623	.	.	.	.
STAD	CAediting_446411	chr5_170811209_+	9.48650670968867e-05	0.497765768940081	.	.	.	.
BRCA	CAediting_446412	chr5_170811211_+	0.00131163922727144	0.260876825500009	.	.	.	.
STAD	CAediting_446412	chr5_170811211_+	0.000131920809074644	0.47012017125252	.	.	.	.

Top

Relation with cancer stages for GABRP

Correlation between Cancer stages and RNA editing frequency

Cancer	Stage_type	CAeditomID	position	P-val	Coeff.
STAD	pathologic_stage	CAediting_446400	chr5_170811135_+	0.00409161518304119	0.365421444123972
STAD	pathologic_stage	CAediting_446412	chr5_170811211_+	0.0330449955921632	0.277955657206344

Top

Relation with survival for GABRP

Correlation between RNA editing and survival

Cancer	CAeditomID	position	KMpvalue	Coxpvalue	CoxHR
BRCA	CAediting_446400	chr5_170811135_+	0.0350623766398762	0.00558973	0.000435334
STAD	CAediting_446412	chr5_170811211_+	0.0465723257865069	0.0200631	0.00119335

Top

RelatedDrugs for GABRP

Approved drugs targeting this gene.
(DrugBank Version 5.1.8 2021-01-03)

Gene	UniProtAcc	DrugBank ID	Drug name	Drug activity	Drug type	Drug status
GABRP	O00591	DB00186	Lorazepam	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved
GABRP	O00591	DB00292	Etomidate	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved
GABRP	O00591	DB00543	Amoxapine	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved
GABRP	O00591	DB00842	Oxazepam	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved
GABRP	O00591	DB00898	Ethanol	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved
GABRP	O00591	DB01189	Desflurane	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved
GABRP	O00591	DB01205	Flumazenil	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved
GABRP	O00591	DB01587	Ketazolam	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved
GABRP	O00591	DB01595	Nitrazepam	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved
GABRP	O00591	DB09118	Stiripentol	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved
GABRP	O00591	DB13872	Lormetazepam	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved
GABRP	O00591	DB00237	Butabarbital	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit
GABRP	O00591	DB00241	Butalbital	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit
GABRP	O00591	DB00306	Talbutal	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit
GABRP	O00591	DB00349	Clobazam	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit
GABRP	O00591	DB00371	Meprobamate	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit
GABRP	O00591	DB00628	Clorazepic acid	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit
GABRP	O00591	DB00683	Midazolam	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit
GABRP	O00591	DB01068	Clonazepam	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit
GABRP	O00591	DB01215	Estazolam	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit
GABRP	O00591	DB01437	Glutethimide	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit
GABRP	O00591	DB01544	Flunitrazepam	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit
GABRP	O00591	DB01559	Clotiazepam	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit
GABRP	O00591	DB01588	Prazepam	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit
GABRP	O00591	DB01589	Quazepam	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit
GABRP	O00591	DB00404	Alprazolam	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit\|investigational
GABRP	O00591	DB00475	Chlordiazepoxide	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit\|investigational
GABRP	O00591	DB00690	Flurazepam	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit\|investigational
GABRP	O00591	DB01558	Bromazepam	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit\|investigational
GABRP	O00591	DB00829	Diazepam	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit\|investigational\|vet_approved
GABRP	O00591	DB00189	Ethchlorvynol	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit\|withdrawn
GABRP	O00591	DB00801	Halazepam	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit\|withdrawn
GABRP	O00591	DB01107	Methyprylon	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|illicit\|withdrawn
GABRP	O00591	DB00231	Temazepam	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|investigational
GABRP	O00591	DB00402	Eszopiclone	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|investigational
GABRP	O00591	DB00555	Lamotrigine	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|investigational
GABRP	O00591	DB00603	Medroxyprogesterone acetate	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|investigational
GABRP	O00591	DB00659	Acamprosate	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|investigational
GABRP	O00591	DB00897	Triazolam	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|investigational
GABRP	O00591	DB01043	Memantine	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|investigational
GABRP	O00591	DB11859	Brexanolone	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|investigational
GABRP	O00591	DB11901	Apalutamide	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|investigational
GABRP	O00591	DB12404	Remimazolam	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|investigational
GABRP	O00591	DB12537	Benzodiazepine	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|investigational
GABRP	O00591	DB01708	Prasterone	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|investigational\|nutraceutical
GABRP	O00591	DB00228	Enflurane	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|investigational\|vet_approved
GABRP	O00591	DB00312	Pentobarbital	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|investigational\|vet_approved
GABRP	O00591	DB00818	Propofol	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|investigational\|vet_approved
GABRP	O00591	DB01028	Methoxyflurane	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|investigational\|vet_approved
GABRP	O00591	DB01956	Taurine	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|nutraceutical
GABRP	O00591	DB00252	Phenytoin	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|vet_approved
GABRP	O00591	DB00753	Isoflurane	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|vet_approved
GABRP	O00591	DB00794	Primidone	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|vet_approved
GABRP	O00591	DB01159	Halothane	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|vet_approved
GABRP	O00591	DB01236	Sevoflurane	Gamma-aminobutyric acid receptor subunit pi	SmallMoleculeDrug	approved\|vet_approved

Top

RelatedDiseases for GABRP

Diseases associated with this gene.
(DisGeNet 7.0)

Gene

Disease ID

Disease name

# pubmeds

Source

	Gene summary
	RNA A-to-I events
	Differntial gene expression between RNA A-to-I edited tumor samples versus normal samples
	Protein coding region RNA A-to-I editings
	The effects of the RNA editing to the miRNA binding sites
	The effects of the RNA editing to the stability of the RNA structures
	Relation with ADAR
	Relation with cancer stages
	Relation with survival state
	Related drugs with this gene
	Related diseases with this gene